Skip to main content
. 2016 Mar 10;6:22978. doi: 10.1038/srep22978

Table 2. Diagnostic performance (with 95% confidence intervals) derived from the 2 × 2 tables of individual studies.

Authors Year TP FN FP TN Inadequate/AS Sensitivity Specificity PLR NLR DOR
Ramesh J 2015 41 2 0 7 4/0 95(84–99) 100(59–100) 15.1(1.0–221.2) 0.06(0.02–0.21) 249.0(10.8–5720.6)
Berzosa M 2015 28 12 0 21 16/0 70(54–83) 100(84–100) 30.6(2.0–477.3) 0.31(0.20–0.50) 98.0(5.5–1749.3)
Fabbri C 2015 48 0 0 20 10/4 100(93–100) 100(83–100) 41.6(2.7–643.0) 0.01(0.00–0.17) 3977.0(76.3–207333.1)
Lee Y 2014 54 3 0 1 0/0 95(85–99) 100(2.5–100) 3.8(0.3–41.5) 0.08(0.02–0.29) 46.7(1.6–1369.5)
Vanbiervliet G 2014 65 5 1 9 9/0 93(84–98) 90(56–100) 9.3(1.4–59.7) 0.08(0.03–0.19) 117.0(12.2–1118.3)
Iwashita T 2013 44 2 0 4 0/0 96(85–99) 100(40–100) 9.5(0.7–131.4) 0.06(0.02–0.20) 160.2(6.6–3880.9)
Hucl T 2013 59 5 0 5 5/0 92(83–97) 100(48–100) 11.0(0.8–156.2) 0.09(0.04–0.21) 119.0(5.8–2448.2)
Larghi A 2013 49 7 0 5 7/0 88(76–95) 100(48–100) 10.4(0.7–148.4) 0.14(0.07–0.29) 72.6(3.6–1451.2)
Krishnan K 2013 17 4 0 2 NA 81(58–95) 100(16–100) 4.8(0.4–60.5) 0.25(0.09–0.65) 19.4(0.8–481.0)
Bang J 2012 22 3 0 3 1/0 88(69–98) 100(29–100) 6.9(0.5–93) 0.15(0.05–0.43) 45.0(1.9–1071.3)
Varadarajulu S 2012 25 0 1 6 3 100(86–100) 86(42–100) 5.2(1.2 –22.1) 0.02(0.01–0.38) 221.0(8.0–6079.1)
Iglesias J 2011 42 3 0 2 2/0 93(82–99) 100(16–100) 5.5(0.4–69.7) 0.09(0.03–0.28) 60.7(2.4–1528.8)
Sakamoto H 2009 9 12 0 3 12/0 43(22–66) 100(29–100) 3.5(0.2–48.3) 0.65(0.39–1.09) 5.3(0.2–115.9)
Thomas T 2009 63 38 0 12 NA 62(52–72) 100(74–100) 16.2(1.1–246.3) 0.39(0.30–0.52) 41.2(2.4–716.4)
Yun SS 2007 25 11 1 15 0/5 69(52–84) 94(70–100) 11.1(1.6–75.0) 0.33(0.20–0.54) 34.1(4.0–291.2)
Ginès A 2005 7 4 0 1 2/0 64(31–89) 100(2.5–100) 2.5(0.2–28.7) 0.50(0.17–1.48) 5.0(0.2–150.9)
Overall 598 111 3 116   84(82–87) 98(93–100) 8.0(4.5–14.4) 0.17(0.10–0.26) 64.0(30.4–134.8)

FN, false negative; FP, false positive; TN, true negative; TP, true positive; Inadequate/AS, inadequate tissue or technical failure/ atypical or suspicious; PLR, positive likelihood ratio; NLR, negative likelihood ratio; DOR, diagnostic odds ratio; NA, not available.